Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Naresh Mandava

Concepts (378)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
24
2025
191
5.410
 Why?
Geographic Atrophy
14
2026
97
4.340
 Why?
Wet Macular Degeneration
8
2025
58
2.680
 Why?
Tomography, Optical Coherence
18
2025
271
2.520
 Why?
Visual Acuity
21
2025
491
2.150
 Why?
Fluorescein Angiography
20
2025
190
2.040
 Why?
Retinal Detachment
6
2023
73
1.900
 Why?
Diabetic Retinopathy
11
2023
209
1.680
 Why?
Retinal Drusen
4
2024
31
1.680
 Why?
Angiogenesis Inhibitors
17
2023
238
1.600
 Why?
Registries
9
2025
2406
1.520
 Why?
Choroid
7
2025
80
1.450
 Why?
Complement Activation
5
2025
399
1.180
 Why?
Vitreous Body
16
2022
117
1.090
 Why?
Vitrectomy
12
2020
73
1.010
 Why?
Multimodal Imaging
2
2025
129
0.970
 Why?
Macula Lutea
2
2023
21
0.950
 Why?
Vascular Endothelial Growth Factor A
13
2024
552
0.940
 Why?
Complement System Proteins
3
2025
314
0.890
 Why?
Retina
10
2021
326
0.810
 Why?
Aged, 80 and over
22
2025
8333
0.800
 Why?
Retinal Diseases
4
2023
101
0.760
 Why?
Antibodies, Monoclonal
9
2011
1505
0.720
 Why?
Biomarkers
8
2025
4295
0.710
 Why?
Retinal Neovascularization
2
2019
29
0.690
 Why?
Choroidal Neovascularization
6
2019
56
0.680
 Why?
National Eye Institute (U.S.)
1
2020
6
0.660
 Why?
Retinal Perforations
4
2015
18
0.640
 Why?
Aged
35
2025
26153
0.640
 Why?
Follow-Up Studies
17
2025
5423
0.640
 Why?
Quarantine
1
2020
31
0.630
 Why?
Estrogen Replacement Therapy
1
2019
143
0.560
 Why?
Retinitis Pigmentosa
3
2021
20
0.550
 Why?
Retinopathy of Prematurity
4
2024
181
0.540
 Why?
Fundus Oculi
8
2026
89
0.530
 Why?
Humans
87
2026
145474
0.500
 Why?
Epiretinal Membrane
3
2010
7
0.490
 Why?
Intraocular Pressure
6
2012
329
0.490
 Why?
Female
55
2025
78844
0.480
 Why?
Automobile Driving
1
2018
157
0.480
 Why?
Fovea Centralis
3
2025
24
0.480
 Why?
Male
53
2025
72842
0.470
 Why?
Scleral Buckling
3
2019
16
0.460
 Why?
Proliferating Cell Nuclear Antigen
2
2007
48
0.450
 Why?
Vitreoretinopathy, Proliferative
2
2007
15
0.450
 Why?
Optic Neuropathy, Ischemic
3
2013
31
0.420
 Why?
RNA, Catalytic
2
2007
191
0.420
 Why?
Self Report
1
2018
870
0.410
 Why?
Recombinant Fusion Proteins
4
2013
666
0.400
 Why?
Optic Disk
4
2025
53
0.390
 Why?
Antibodies, Monoclonal, Humanized
11
2015
992
0.390
 Why?
Surveys and Questionnaires
5
2025
6066
0.380
 Why?
Middle Aged
34
2025
36215
0.380
 Why?
Prospective Studies
9
2025
8057
0.380
 Why?
Research Design
1
2019
1137
0.370
 Why?
Bevacizumab
11
2015
168
0.370
 Why?
Retinal Necrosis Syndrome, Acute
2
2013
7
0.360
 Why?
Retrospective Studies
26
2025
17291
0.360
 Why?
Retinal Vein Occlusion
2
2015
14
0.350
 Why?
Image Processing, Computer-Assisted
3
2026
779
0.350
 Why?
Pandemics
1
2020
1707
0.350
 Why?
Photography
4
2015
119
0.340
 Why?
Retinal Pigment Epithelium
3
2024
79
0.340
 Why?
Uveal Diseases
2
2013
6
0.340
 Why?
Endophthalmitis
3
2017
46
0.330
 Why?
Disease Progression
6
2025
2864
0.330
 Why?
Colorado
8
2025
4553
0.330
 Why?
Cross-Sectional Studies
8
2025
5904
0.330
 Why?
Cataract
2
2020
238
0.320
 Why?
Diagnostic Techniques, Ophthalmological
2
2015
53
0.310
 Why?
Complement Factor B
2
2022
106
0.310
 Why?
Glycogen Storage Disease Type IIb
2
2007
27
0.300
 Why?
Visual Fields
3
2022
116
0.300
 Why?
Vision, Low
4
2022
16
0.290
 Why?
Pigment Epithelium of Eye
2
2006
36
0.290
 Why?
Injections
6
2010
199
0.290
 Why?
Ophthalmology
2
2013
119
0.270
 Why?
Ocular Hypertension
1
2009
70
0.270
 Why?
Risk Factors
11
2025
10885
0.270
 Why?
Health Knowledge, Attitudes, Practice
2
2014
1419
0.270
 Why?
Phacoemulsification
3
2020
123
0.260
 Why?
Macular Edema
2
2015
49
0.260
 Why?
Encephalitis, Herpes Simplex
1
2007
21
0.260
 Why?
Optic Nerve Injuries
1
2007
9
0.260
 Why?
Quantum Dots
2
2021
37
0.260
 Why?
Glaucoma
3
2025
250
0.260
 Why?
von Hippel-Lindau Disease
1
2007
12
0.250
 Why?
Papilledema
1
2007
44
0.250
 Why?
Glucocorticoids
2
2013
531
0.250
 Why?
Vision Disorders
2
2022
179
0.250
 Why?
Puerperal Disorders
1
2007
36
0.240
 Why?
Triamcinolone Acetonide
1
2006
20
0.240
 Why?
Ocular Hypotension
1
2006
10
0.240
 Why?
Herpesvirus 1, Human
1
2007
84
0.240
 Why?
Ciliary Body
1
2006
40
0.230
 Why?
Myopia
1
2006
59
0.230
 Why?
Telangiectasis
1
2005
7
0.230
 Why?
Chemokine CCL5
2
2023
40
0.230
 Why?
Granuloma
1
2006
97
0.230
 Why?
Optical Imaging
1
2026
61
0.220
 Why?
Time Factors
5
2025
7123
0.220
 Why?
DNA, Viral
1
2007
356
0.220
 Why?
Retinal Vessels
1
2005
77
0.210
 Why?
Retinal Ganglion Cells
4
2022
121
0.210
 Why?
Fluorocarbons
1
2005
120
0.210
 Why?
Diseases in Twins
1
2024
116
0.210
 Why?
Birth Weight
2
2024
514
0.200
 Why?
Laser Therapy
2
2021
144
0.200
 Why?
Diabetes Mellitus
2
2023
1097
0.200
 Why?
Vision Tests
1
2023
22
0.200
 Why?
Twins
1
2024
152
0.200
 Why?
Temporal Arteries
2
2015
45
0.200
 Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
109
0.190
 Why?
Hemianopsia
1
2022
11
0.190
 Why?
Disease Models, Animal
4
2012
4560
0.180
 Why?
Ophthalmoscopy
2
2015
38
0.170
 Why?
Posterior Capsulotomy
1
2021
8
0.170
 Why?
Posterior Capsule of the Lens
1
2021
11
0.170
 Why?
Capsule Opacification
1
2021
22
0.170
 Why?
Lasers, Solid-State
1
2021
22
0.170
 Why?
Ranibizumab
5
2013
21
0.160
 Why?
Sickness Impact Profile
1
2020
62
0.160
 Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.160
 Why?
Herpesvirus 3, Human
2
2015
343
0.160
 Why?
Artificial Intelligence
1
2025
381
0.160
 Why?
Reproducibility of Results
3
2025
3413
0.160
 Why?
Nerve Fibers
2
2010
105
0.160
 Why?
Neurodegenerative Diseases
1
2022
142
0.150
 Why?
Electrodes, Implanted
2
2018
114
0.150
 Why?
Machine Learning
1
2026
587
0.150
 Why?
Intravitreal Injections
6
2020
71
0.150
 Why?
Protective Factors
1
2019
99
0.150
 Why?
Odds Ratio
2
2019
1082
0.150
 Why?
Complement Membrane Attack Complex
1
2019
38
0.150
 Why?
Ischemia
2
2017
422
0.150
 Why?
Complement C3a
1
2019
40
0.150
 Why?
C-Reactive Protein
1
2021
422
0.150
 Why?
Intraoperative Complications
1
2020
157
0.140
 Why?
Visual Prosthesis
1
2018
1
0.140
 Why?
Cohort Studies
5
2020
6013
0.130
 Why?
Metformin
1
2021
329
0.130
 Why?
Orbit
2
2010
66
0.130
 Why?
Anterior Eye Segment
1
2017
10
0.130
 Why?
Quality of Life
4
2022
3204
0.130
 Why?
Labor, Induced
1
2017
40
0.120
 Why?
Gestational Age
4
2024
987
0.120
 Why?
Labor, Obstetric
1
2017
68
0.120
 Why?
Giant Cell Arteritis
2
2015
48
0.120
 Why?
Postoperative Complications
3
2021
2970
0.120
 Why?
Strabismus
1
2017
71
0.120
 Why?
Laser Coagulation
3
2012
80
0.120
 Why?
Retinal Degeneration
2
2015
40
0.120
 Why?
Ophthalmologic Surgical Procedures
1
2017
90
0.120
 Why?
Blindness
3
2013
51
0.110
 Why?
Phenotype
3
2022
3155
0.110
 Why?
Gyrate Atrophy
1
2015
2
0.110
 Why?
Immunosuppressive Agents
2
2013
838
0.110
 Why?
Vitreoretinal Surgery
1
2015
4
0.110
 Why?
Multivariate Analysis
1
2019
1547
0.110
 Why?
Recovery of Function
1
2019
716
0.110
 Why?
Case-Control Studies
2
2020
3623
0.110
 Why?
Vitreous Detachment
1
2015
6
0.110
 Why?
Needles
1
2015
63
0.110
 Why?
Encephalitis, Varicella Zoster
1
2015
17
0.110
 Why?
Incidence
2
2020
2923
0.110
 Why?
Biopsy, Needle
1
2015
185
0.110
 Why?
Eye Infections, Bacterial
1
2015
45
0.110
 Why?
Rats, Inbred BN
3
2011
56
0.110
 Why?
Antiviral Agents
2
2013
769
0.110
 Why?
Logistic Models
1
2019
2134
0.100
 Why?
Proteins
1
2020
1023
0.100
 Why?
Wounds, Gunshot
2
2010
258
0.100
 Why?
Treatment Outcome
7
2021
11772
0.100
 Why?
Inflammation
3
2023
2878
0.100
 Why?
Oculomotor Muscles
1
2014
86
0.100
 Why?
Anti-Inflammatory Agents
2
2021
477
0.100
 Why?
Drug Packaging
2
2011
41
0.100
 Why?
Uvea
1
2013
4
0.100
 Why?
Exchange Transfusion, Whole Blood
1
2013
19
0.100
 Why?
Fibrin
1
2014
84
0.100
 Why?
Uveomeningoencephalitic Syndrome
1
2013
8
0.100
 Why?
Retinal Artery Occlusion
1
2013
10
0.100
 Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
 Why?
Tendons
1
2014
131
0.100
 Why?
Proteomics
1
2020
1188
0.100
 Why?
Cytomegalovirus Retinitis
1
2013
22
0.100
 Why?
Isoxazoles
1
2013
56
0.100
 Why?
Lymphoproliferative Disorders
1
2013
57
0.100
 Why?
Premature Birth
1
2017
388
0.090
 Why?
Silicon
1
2012
19
0.090
 Why?
Fatty Acids, Omega-3
1
2014
143
0.090
 Why?
Lens Subluxation
1
2012
4
0.090
 Why?
Trabecular Meshwork
1
2013
74
0.090
 Why?
Adult
15
2020
40777
0.090
 Why?
Viremia
1
2013
160
0.090
 Why?
Exanthema
1
2013
86
0.090
 Why?
Uveitis, Posterior
1
2012
12
0.090
 Why?
Electric Stimulation Therapy
1
2012
62
0.090
 Why?
Diagnostic Imaging
1
2015
337
0.090
 Why?
Fluocinolone Acetonide
1
2012
15
0.090
 Why?
Diagnosis, Differential
4
2013
1508
0.090
 Why?
Microsurgery
1
2012
76
0.090
 Why?
Placenta
1
2018
786
0.080
 Why?
Vascular Endothelial Growth Factors
1
2011
78
0.080
 Why?
Fluorescein-5-isothiocyanate
2
2009
36
0.080
 Why?
Electroretinography
2
2012
50
0.080
 Why?
Drug Storage
1
2011
53
0.080
 Why?
Dextrans
2
2009
84
0.080
 Why?
Particulate Matter
2
2011
326
0.080
 Why?
Global Health
1
2014
403
0.080
 Why?
Silicone Oils
1
2011
37
0.080
 Why?
Dissection
1
2011
57
0.080
 Why?
Health Care Costs
1
2014
425
0.080
 Why?
Antioxidants
1
2014
550
0.080
 Why?
Infliximab
2
2007
111
0.080
 Why?
Lysosomal-Associated Membrane Protein 2
2
2007
32
0.080
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
443
0.080
 Why?
Protein Multimerization
1
2011
204
0.080
 Why?
Clinical Trials, Phase II as Topic
1
2009
75
0.080
 Why?
Clinical Trials, Phase I as Topic
1
2009
50
0.080
 Why?
Bacteria
1
2015
765
0.080
 Why?
Anemia, Sickle Cell
1
2013
318
0.070
 Why?
Herpes Zoster
1
2013
319
0.070
 Why?
Tonometry, Ocular
1
2009
103
0.070
 Why?
Scotoma
1
2008
6
0.070
 Why?
Rats
4
2012
5584
0.070
 Why?
United States
3
2020
16098
0.070
 Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
253
0.070
 Why?
Algorithms
2
2026
1845
0.070
 Why?
Retinal Artery
1
2007
17
0.070
 Why?
Vitreous Hemorrhage
1
2007
10
0.060
 Why?
Cerebral Angiography
1
2007
119
0.060
 Why?
RNA, Messenger
2
2007
2803
0.060
 Why?
Acyclovir
1
2007
98
0.060
 Why?
Dose-Response Relationship, Drug
2
2009
2028
0.060
 Why?
Frameshift Mutation
1
2006
31
0.060
 Why?
Conjunctival Neoplasms
1
2005
7
0.060
 Why?
Ultrasonography
2
2007
785
0.060
 Why?
Internationality
2
2018
156
0.060
 Why?
Secondary Prevention
1
2007
251
0.060
 Why?
Eye Injuries, Penetrating
1
2005
19
0.060
 Why?
Indocyanine Green
1
2005
42
0.060
 Why?
Eye Foreign Bodies
1
2005
23
0.060
 Why?
beta-Thalassemia
1
2006
40
0.060
 Why?
Animals
7
2014
38030
0.060
 Why?
Coloring Agents
1
2005
89
0.060
 Why?
Eye Injuries
1
2006
53
0.060
 Why?
Tumor Necrosis Factor-alpha
2
2007
1217
0.060
 Why?
Staining and Labeling
1
2005
153
0.060
 Why?
Uncertainty
1
2026
146
0.060
 Why?
Infant, Newborn
3
2024
6447
0.050
 Why?
Uveitis
1
2006
149
0.050
 Why?
Antihypertensive Agents
1
2009
519
0.050
 Why?
Mydriatics
1
2004
10
0.050
 Why?
Metals
1
2005
136
0.050
 Why?
Pupil
1
2004
22
0.050
 Why?
Pregnancy
3
2018
7202
0.050
 Why?
Polymerase Chain Reaction
1
2007
1041
0.050
 Why?
Sclera
2
2014
36
0.050
 Why?
Hospitals, County
1
2023
11
0.050
 Why?
Cardiomyopathy, Dilated
1
2007
356
0.050
 Why?
Image Interpretation, Computer-Assisted
1
2026
288
0.050
 Why?
Sensitivity and Specificity
2
2008
1997
0.050
 Why?
Observer Variation
1
2004
357
0.050
 Why?
Enzyme-Linked Immunosorbent Assay
2
2019
848
0.050
 Why?
Fibroblasts
2
2013
1025
0.050
 Why?
Chimera
1
2002
61
0.050
 Why?
Interleukin-4
1
2023
207
0.050
 Why?
Enzyme Stability
1
2002
73
0.050
 Why?
Complement Factor I
1
2022
12
0.050
 Why?
Endopeptidases
1
2002
80
0.050
 Why?
Double-Blind Method
1
2007
2062
0.050
 Why?
Preventive Medicine
1
2002
39
0.050
 Why?
Young Adult
6
2019
14218
0.050
 Why?
Aqueous Humor
1
2022
38
0.050
 Why?
Blood
1
2002
107
0.040
 Why?
Autoimmune Diseases
1
2006
468
0.040
 Why?
Coculture Techniques
1
2002
247
0.040
 Why?
Albumins
1
2022
119
0.040
 Why?
Retreatment
2
2012
79
0.040
 Why?
Rabbits
1
2002
652
0.040
 Why?
Fibrinogen
1
2022
180
0.040
 Why?
Lenses, Intraocular
1
2021
49
0.040
 Why?
Cells, Cultured
2
2013
4148
0.040
 Why?
Cell Division
1
2002
756
0.040
 Why?
Equipment Design
2
2014
525
0.040
 Why?
Drug Compounding
2
2011
107
0.040
 Why?
Electric Stimulation
1
2021
276
0.040
 Why?
Chronic Disease
1
2006
1808
0.040
 Why?
Immunologic Factors
1
2022
260
0.040
 Why?
Cell Survival
2
2013
1100
0.040
 Why?
Melanoma
1
2005
759
0.040
 Why?
Postoperative Period
1
2019
351
0.040
 Why?
Immunity, Maternally-Acquired
1
2018
19
0.030
 Why?
Combined Modality Therapy
2
2013
1266
0.030
 Why?
Primary Health Care
1
2008
1735
0.030
 Why?
Infant
3
2020
10077
0.030
 Why?
Prevalence
2
2015
2865
0.030
 Why?
Lipids
1
2002
707
0.030
 Why?
Iris Diseases
1
2017
7
0.030
 Why?
Choroid Diseases
1
2017
10
0.030
 Why?
Longitudinal Studies
1
2025
2953
0.030
 Why?
Prosthesis Implantation
1
2018
154
0.030
 Why?
Parity
1
2017
111
0.030
 Why?
Sex Characteristics
1
2022
782
0.030
 Why?
Infant, Low Birth Weight
1
2017
156
0.030
 Why?
Referral and Consultation
1
2022
867
0.030
 Why?
Mental Health
1
2022
793
0.030
 Why?
Microbiological Techniques
1
2015
30
0.030
 Why?
Risk
1
2018
919
0.030
 Why?
Colony Count, Microbial
1
2015
89
0.030
 Why?
Endotamponade
1
2015
2
0.030
 Why?
Myopia, Degenerative
1
2015
5
0.030
 Why?
Tenon Capsule
1
2014
3
0.030
 Why?
Tissue Adhesions
1
2015
34
0.030
 Why?
Cerebral Arterial Diseases
1
2015
50
0.030
 Why?
Conjunctiva
1
2014
52
0.030
 Why?
Biometry
1
2014
66
0.030
 Why?
Atrophy
1
2015
199
0.030
 Why?
Lens Implantation, Intraocular
1
2015
80
0.030
 Why?
Adolescent
3
2012
22529
0.030
 Why?
Fetus
1
2018
804
0.020
 Why?
T-Lymphocytes
1
2022
1996
0.020
 Why?
Early Diagnosis
1
2014
251
0.020
 Why?
Safety-net Providers
1
2014
130
0.020
 Why?
Adaptation, Ocular
1
2012
6
0.020
 Why?
Dark Adaptation
1
2012
13
0.020
 Why?
Rats, Mutant Strains
1
2012
19
0.020
 Why?
Sclerostomy
1
2012
4
0.020
 Why?
Infant, Premature
1
2017
619
0.020
 Why?
Cytomegalovirus
1
2013
168
0.020
 Why?
Mothers
1
2018
765
0.020
 Why?
Child, Preschool
1
2007
11853
0.020
 Why?
Cell Count
1
2012
319
0.020
 Why?
Drug Implants
1
2012
83
0.020
 Why?
Hypoglycemic Agents
1
2021
1399
0.020
 Why?
Gold
1
2012
116
0.020
 Why?
Bruch Membrane
1
2011
6
0.020
 Why?
Swine
1
2014
825
0.020
 Why?
Polyglycolic Acid
1
2011
44
0.020
 Why?
Miniaturization
1
2011
22
0.020
 Why?
Administration, Oral
1
2013
866
0.020
 Why?
Drug Stability
1
2011
169
0.020
 Why?
Delayed-Action Preparations
1
2011
189
0.020
 Why?
Chromatography, Gel
1
2010
130
0.020
 Why?
Fluorescein
1
2010
24
0.020
 Why?
Immunoglobulin Light Chains
1
2010
52
0.020
 Why?
Immunoglobulin Heavy Chains
1
2010
86
0.020
 Why?
Molecular Weight
1
2010
312
0.020
 Why?
Comorbidity
1
2015
1661
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2010
331
0.020
 Why?
Microfluidic Analytical Techniques
1
2010
79
0.020
 Why?
Aptamers, Nucleotide
1
2010
87
0.020
 Why?
Lactic Acid
1
2011
295
0.020
 Why?
Particle Size
1
2011
381
0.020
 Why?
Reference Values
1
2010
798
0.020
 Why?
Poverty Areas
1
2008
43
0.020
 Why?
Community Health Centers
1
2008
59
0.020
 Why?
Fluorescent Dyes
1
2010
333
0.020
 Why?
Optic Nerve Diseases
1
2008
49
0.020
 Why?
Kaplan-Meier Estimate
1
2010
969
0.020
 Why?
Models, Biological
1
2015
1764
0.020
 Why?
Kidney Transplantation
1
2013
712
0.020
 Why?
Polyethylene Glycols
1
2011
649
0.010
 Why?
Pilot Projects
1
2012
1891
0.010
 Why?
Imaging, Three-Dimensional
1
2010
583
0.010
 Why?
Pedigree
1
2007
515
0.010
 Why?
Infusions, Intravenous
1
2006
428
0.010
 Why?
Adrenal Cortex Hormones
1
2008
484
0.010
 Why?
Anti-Bacterial Agents
1
2015
1923
0.010
 Why?
Severity of Illness Index
1
2011
2930
0.010
 Why?
Mass Screening
1
2008
1360
0.010
 Why?
Tomography, X-Ray Computed
1
2010
2769
0.010
 Why?
Risk Assessment
1
2008
3747
0.010
 Why?
Diabetes Mellitus, Type 2
1
2012
2588
0.010
 Why?
Aging
1
2008
1969
0.010
 Why?
Mutation
1
2007
4075
0.010
 Why?
Child
1
2012
22707
0.010
 Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (378) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)